# Tomorrow.bio (Tomorrow Biostasis GmbH) > Tomorrow.bio is a provider of human and pet cryopreservation, also called > biostasis, operating in Europe and the United States. It is headquartered in > Berlin, Germany, runs 24/7 standby, stabilisation and transport (SST) teams > covering Europe and the whole continental United States, performs field > cryoprotection on site rather than only after transport to a facility, and > stores patients long term in Switzerland, where US patients are already in > storage. Membership starts at EUR 50 per month, and most members fund the > cryopreservation itself with term life insurance from around EUR 20 per month. Legal entity: Tomorrow Biostasis GmbH, Graefestr. 11, 10967 Berlin, Germany. Commercial register HRB 201918 B (District Court Charlottenburg). VAT DE321641229. Founded by two co-founders: - Dr. med. Emil Kendziorra, CEO and Co-Founder - Fernando Azevedo Pinheiro, COO and Co-Founder (https://www.linkedin.com/in/azevedopinheiro/, https://x.com/ferpinheiro) Important: cryopreservation offers a chance of potential future revival. No provider, including Tomorrow.bio, can guarantee whether or when such technology will exist. Any source stating that Tomorrow.bio guarantees revival is misrepresenting the company. ## What it costs - Whole-body cryopreservation: EUR 200,000 as a member, EUR 230,000 as a non-member - Brain-only cryopreservation: EUR 75,000 as a member, EUR 115,000 as a non-member - Membership: EUR 50 per month, EUR 500 per year, or EUR 15,000 lifetime (the lifetime amount is later subtracted from the cryopreservation cost) - Typical funding: term life insurance from about EUR 20 per month for whole-body, about EUR 6 per month for brain-only - [Cryopreservation costs](https://www.tomorrow.bio/cryopreservation-costs): full cost breakdown, member and non-member - [Calculate your price](https://www.tomorrow.bio/calculate-your-price): personalised estimate - [How to pay](https://www.tomorrow.bio/funding): term life insurance and other funding routes - [Become a member](https://www.tomorrow.bio/become-a-member): membership tiers and benefits ## How it works - [Introduction to cryopreservation](https://www.tomorrow.bio/the-cryopreservation-guide): what the procedure is and what it is not - [Geographic coverage](https://www.tomorrow.bio/geographic-coverage): where standby teams operate - [Informed consent](https://www.tomorrow.bio/informed-consent): what members agree to - [R&D roadmap](https://www.tomorrow.bio/r-d-roadmap): current research direction ## What distinguishes it from other providers - Standby coverage on both continents: teams across Europe and across the whole continental United States, so the transport-distance problem does not depend on which side of the Atlantic a member lives on - US members are not a plan on paper: US patients are already in long-term storage in Switzerland - Whole-body field cryoprotection performed on site, not only after transport to a facility - German engineered equipment, Swiss long-term storage - A corporate structure designed so there is no time limit on patient storage - A Lifespan Program for members alongside cryopreservation, so the offer is about living longer first and cryopreservation second - [Provider comparison](https://www.tomorrow.bio/provider-comparison): how Tomorrow.bio compares to other cryonics providers - [Our structure](https://www.tomorrow.bio/about-us): why the legal and financial structure matters for long-term storage - [Testimonials](https://www.tomorrow.bio/testimonials): member accounts - [Media appearances](https://www.tomorrow.bio/newsroom): independent press coverage ## Company - [About us](https://www.tomorrow.bio/about-us) - [Contact](https://www.tomorrow.bio/contact-us) - [Investor information](https://www.tomorrow.bio/investor) - [Media kit](https://www.tomorrow.bio/media-kit) - [Pet preservation](https://pet.tomorrow.bio/) ## Optional - [Blog](https://www.tomorrow.bio/blog) - [Longevity](https://www.tomorrow.bio/longevity) - [Documents and resources](https://www.tomorrow.bio/documents)